🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ashwin Sachdeva

Salford Royal NHS Foundation Trust

ORCID: 0000-0002-7359-7114

Also affiliated with Cancer Research UK, University of Manchester, Manchester University NHS Foundation Trust, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol”.

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885
N/A
0.573DataRank · unranked
17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042
N/A
0DataRank · unranked
24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003
N/A
0DataRank · unranked
2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more